Loss of a Small Region Around the PTEN Locus Is a Major Chromosome 10 Alteration in Prostate Cancer Xenografts and Cell Lines

Genes Chromosomes and Cancer

Volumn 39, Issue 3, 2004, Pages 171-184

  Hermans, Karin G ^a   Van Alewijk, Dirk C ^a   Veltman, Joris A ^b   Van Weerden, Wytske ^a   Van Kessel, Ad Geurts ^b   Trapman, Jan ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ALLELE; ANIMAL; ARTICLE; CHROMOSOME 10; CHROMOSOME 10P; CHROMOSOME 10Q; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA FLANKING REGION; DNA MICROARRAY; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE IDENTIFICATION; GENE INACTIVATION; GENE LOCUS; GENE LOSS; GENE MUTATION; GENETIC MARKER; GENETICS; HOMOZYGOSITY; HUMAN; HUMAN CELL; MALE; METHODOLOGY; MISSENSE MUTATION; MOUSE; MUTATION; NUCLEIC ACID HYBRIDIZATION; NUDE MOUSE; PATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CARCINOMA; PROSTATE TUMOR; STRUCTURAL GENE; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; XENOGRAFT;

3' FLANKING REGION; 5' FLANKING REGION; ALLELES; ANIMALS; CELL LINE, TUMOR; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 10; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HUMANS; MALE; MICE; MICE, NUDE; MUTATION; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 1142274291     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10311     Document Type: Article

References (66)

1. Alers JC, Rochat J, Krijtenburg PJ, Hop WC, Kranse R, Rosenberg C, Tanke HJ, Schroder FH, van Dekken H. 2000. Identification of genetic markers for prostatic cancer progression. Lab Invest 80:931-942.
2. Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, Jen J, Isaacs WB, Bova GS, Sidransky D. 1997. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 57:4997-5000.
3. Cappellen D, Gil Diez de Medina S, Chopin D, Thiery JP, Radvanyi F. 1997. Frequent loss of heterozygosity on chromosome 10q in muscle-invasive transitional cell carcinomas of the bladder. Oncogene 14:3059-3066.
4. Chen C, Hyytinen ER, Sun X, Helin HJ, Koivisto PA, Frierson HF, Jr., Vessella RL, Dong JT. 2003. Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol 162:1349-1354.
5. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH. 1996. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56:3091-3102.
6. Clark J, Edwards S, Feber A, Flohr P, John M, Giddings I, Crossland S, Stratton MR, Wooster R, Campbell C, Cooper CS. 2003. Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays. Oncogene 22:1247-1252.
7. Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, Pandolfi PP. 2001. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet 27:222-224.
8. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV. 1995. Mutation of the MXI1 gene in prostate cancer. Nat Genet 9:249-255.
9. Edelhoff S, Ayer DE, Zervos AS, Steingrimsson E, Jenkins NA, Copeland NG, Eisenman RN, Brent R, Disteche CM. 1994. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19. Oncogene 9:665-668.
10. Feilotter HE, Nagai MA, Boag AH, Eng C, Mulligan LM. 1998. Analysis of PTEN and the 10q23 region in primary prostate carcinomas. Oncogene 16:1743-1748.
11. Fujimoto M, Fults DW, Thomas GA, Nakamura Y, Heilbrun MP, White R, Story JL, Naylor SL, Kagan-Hallet KS, Sheridan PJ. 1989. Loss of heterozygosity on chromosome 10 in human glioblastoma multiforme. Genomics 4:210-214.
12. Fukuhara H, Maruyama T, Nomura S, Oshimura M, Kitamura T, Sekiya T, Murakami Y. 2001. Functional evidence for the presence of tumor suppressor gene on chromosome 10p15 in human prostate cancers. Oncogene 20:314-319.
13. Gray IC, Phillips SM, Lee SJ, Neoptolemos JP, Weissenbach J, Spurr NK. 1995. Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 55:4800-4803.
14. Grav IC, Stewart LM, Phillips SM, Hamilton JA, Gray NE, Watson GJ, Spurr NK, Snary D. 1998. Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN. Br J Cancer 78:1296-1300.
15. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. 2001. Cancer statistics, 2001. CA Cancer J Clin 51:15-36.
16. Helenius MA, Saramaki OR, Linja MJ, Tammela TL, Visakorpi T. 2001. Amplification of urokinase gene in prostate cancer. Cancer Res 61:5340-5344.
17. Hoehn W, Schroeder FH, Reimann JF, Joebsis AC, Hermanek P. 1980. Human prostatic adenocarcinoma: some characteristics of a serially transplantable line in nude mice (PC 82). Prostate 1:95-104.
18. Hoehn W, Wagner M, Riemann JF, Hermanek P, Williams E, Walther R, Schrueffer R. 1984. Prostatic adenocarcinoma PC EW, a new human tumor line transplantable in nude mice. Prostate 5:445-452.
19. Ittmann M. 1996. Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res 56:2143-2147.
20. James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP, Cavenee WK. 1988. Clonal genomic alterations in glioma malignancy stages. Cancer Res 48:5546-5551.
21. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
22. Kim MJ, Cardiff RD, Desai N, Banach-Petrosky WA, Parsons R, Shen MM, Abate-Shen C. 2002. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA 99:2884-2889.
23. Kim SK, Ro JY, Kemp BL, Lee JS, Kwon TJ, Hong WK, Mao L. 1998. Identification of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer. Oncogene 17:1749-1753.
24. Komiya A, Suzuki H, Ueda T, Yatani R, Emi M, Ito H, Shimazaki J. 1996. Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer. Genes Chromosomes Cancer 17:245-253.
25. Kwabi-Addo B, Giri D, Schmidt K, Podsypanina K, Parsons R, Greenberg N, Ittmann M. 2001. Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression. Proc Natl Acad Sci USA 98:11563-11568.
26. Lahoz EG, Xu L, Schreiber-Agus N, DePinho RA. 1994. Suppression of Myc, but not E1a, transformation activity by Max-associated proteins, Mad and Mxi1. Proc Natl Acad Sci USA 91:5503-5507.
27. Laitinen S, Karhu R, Sawyers CL, Vessella RL, Visakorpi T. 2002. Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization. Genes Chromosomes Cancer 35:66-73.
28. Leube B, Drechsler M, Muhlmann K, Schafer R, Schulz WA, Santourlidis S, Anastasiadis A, Ackermann R, Visakorpi T, Muller W, Royer-Pokora B. 2002. Refined mapping of allele loss at chromosome 10q23-26 in prostate cancer. Prostate 50:135-144.
29. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann NI, Tycko B, Hibshoosh H, Wigler MH, Parsons R. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943-1947.
30. Lieberfarb ME, Lin M, Lechpammer M, Li C, Tanenbaum DM, Febbo PG, Wright RL, Shim J, Kantoff PW, Loda M, Meyerson M, Sellers WR. 2003. Genome-wide loss of heterozygosity analysis from laser capture microdissected prostate cancer using single nucleotide polymorphic allele (SNP) arrays and a novel bioinformatics platform dChipSNP. Cancer Res 63:4781-4785.
31. McMenamin ME, Soung P, Perera S, Kaplan I, Loda M, Sellers WR. 1999. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res 59:4291-4296.
32. Mollenhauer J, Wiemann S, Scheurlen W, Korn B, Hayashi Y, Wilgenbus KK, von Deimling A, Poustka A. 1997. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours. Nat Genet 17:32-39.
33. Mollenhauer J, Holmskov U, Wiemann S, Krebs I, Herbertz S, Madsen J, Kioschis P, Coy JF, Poustka A. 1999. The genomic structure of the DMBT1 gene: evidence for a region with susceptibility to genomic instability. Oncogene 18:6233-6240.
34. Mollenhauer J, Herbertz S, Holmskov U, Tolnay M, Krebs I, Merlo A, Schroder HD, Maier D, Breitling F, Wiemann S, Grone HJ, Poustka A. 2000. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer. Cancer Res 60:1704-1710.
35. Morita R, Saito S, Ishikawa J, Ogawa O, Yoshida O, Yamakawa K, Nakamura Y. 1991. Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Cancer Res 51:5817-5820.
36. Nagase S, Sato S, Tezuka F, Wada Y, Yajima A, Horii A. 1996. Deletion mapping on chromosome 10q25-q26 in human endometrial cancer. Br J Cancer 74:1979-1983.
37. Narla G, Heath KE, Reeves HL, Li D, Giono LE, Kimmelman AC, Glucksman MJ, Narla J, Eng FJ, Chan AM, Ferrari AC, Martignetti JA, Friedman SL. 2001. KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 294:2563-2566.
38. Nupponen NN, Hyytinen ER, Kallioniemi AH, Visakorpi T. 1998a. Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization. Cancer Genet Cytogenet 101:53-57.
39. Nupponen NN, Kakkola L, Koivisto P, Visakorpi T. 1998b. Genetic alterations in hormone-refractory recurrent prostate carcinomas. Am J Pathol 153:141-148.
40. Pan Y, Kytola S, Farnebo F, Wang N, Lui WO, Nupponen N, Isola J, Visakorpi T, Bergerheim US, Larsson C. 1999. Characterization of chromosomal abnormalities in prostate cancer cell lines by spectral karyotyping. Cytogenet Cell Genet 87:225-232.
41. Pan Y, Lui WO, Nupponen N, Larsson C, Isola J, Visakorpi T, Bergerheim US, Kytola S. 2001. 5q11, 8p11, and 10q22 are recurrent chromosomal breakpoints in prostate cancer cell lines. Genes Chromosomes Cancer 30:187-195.
42. Peiffer SL, Herzog TJ, Tribune DJ, Mutch DG, Gersell DJ, Goodfellow PJ. 1995. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res 55:1922-1926.
43. Pesche S, Latil A, Muzeau F, Cussenot O, Fournier G, Longy M, Eng C, Lidereau R. 1998. PTEN/MMAC1/TEP1 involvement in primary prostate cancers. Oncogene 16:2879-2883.
44. Prochownik EV, Eagle Grove L, Deubler D, Zhu XL, Stephenson RA, Rohr LR, Yin X, Brothman AR. 1998. Commonly occurring loss and mutation of the MXI1 gene in prostate cancer. Genes Chromosomes Cancer 22:295-304.
45. Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH. 1997. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57:4187-4190.
46. Reifenberger J, Wolter M, Bostrom J, Buschges R, Schulte KW, Megahed NI, Ruzicka T, Reifenberger G. 2000. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas. Virchows Arch 436:487-493.
47. Rempel SA, Schwechheimer K, Davis RL, Cavenee WK, Rosenblum ML. 1993. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res 53:2386-2392.
48. Sambrook J, Russell DW. 2001. Molecular cloning. A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
49. Shapiro DN, Valentine V, Eagle L, Yin X, Morris SW, Prochownik EV. 1994. Assignment of the human MAD and MXI1 genes to chromosomes 2p12-p13 and 10q24-q25. Genomics 23:282-285.
50. Speaks SL, Sanger WG, Masih AS, Harrington DS, Hess M, Armitage JO. 1992. Recurrent abnormalities of chromosome bands 10q23-25 in non-Hodgkin's lymphoma. Genes Chromosomes Cancer 5:239-243.
51. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hartier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV. 1997. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356-362.
52. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R, Ellenson LH. 1997. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57:3935-3940.
53. Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Nagger A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WK, Fujii G, Berson A, Steck PA. 1997. MMAC1/PTEN mutation in primary tumor specimens and tumor cell lines. Cancer Res 57:5221-5225.
54. Trybus TM, Burgess AC, Wojno KJ, Glover TW, Macoska JA. 1996. Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer. Cancer Res 56:2263-2267.
55. van Weerden WM, de Ridder CM, Verdaasdonk CL, Romijn JC, van der Kwast TH, Schroder FH, van Steenbrugge GJ. 1996. Development of seven new human prostate tumor xenograft models and their histopathological characterization. Am J Pathol 149:1055-1062.
56. Veltman JA, Schoenmakers EF, Eussen BH, Janssen I, Merkx G, van Cleef B, van Ravenswaaij CM, Brunner HG, Smeets D, Geurts van Kessel A. 2002. High-throughput analysis of subtelomeric chromosome rearrangements by use of array-based comparative genomic hybridization. Am J Hum Genet 70:1269-1276.
57. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo WL, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN, Waldman FM. 2003. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 63:2872-Z880.
58. Verhagen PC, Hermans KG, Brok MO, van Weerden WM, Tilanus MG, de Weger RA, Boon TA, Trapman J. 2002. Deletion of chromosomal region 6q14-16 in prostate cancer. Int J Cancer 102:142-147.
59. Visakorpi T, Kallioniemi AH, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP. 1995. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
60. Vissers LE, de Vries BB, Osoegawa K, Janssen I, Feuth T, Choy CO, Strattman H, van der Vliet W, Huys EH, van Rijk A, Smeets D, van Ravenswaaij-Arts CM, Knoers N, van der Burgt I, de Jong PJ, Brunner HG, Geurts van Kessel A, Schoenmakers EF, Veltman JA. Array-based comparative genomic hybridization for the genome wide detection of submicroscopic chromosome abnormalities. Am J Hum Genet. In press.
61. Vlietstra RJ, van Alewijk DC, Hermans KG, van Steenbrugge GJ, Trapman J. 1998. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res 58:2720-2723.
62. Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R. 1997. Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57:4183-4186.
63. Wang Si, Parsons R, Ittmann M. 1998. Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas. Clin Cancer Res 4:811-815.
64. Whang YE, Wu X, Suzuki H, Reiter RE, Tran C, Vessella RL, Said JW, Isaacs WB, Sawyers CL. 1998. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci USA 95:5246-5250.
65. Xu ZH, Freimuth RR, Eckloff B, Wieben E, Weinshilboum RM. 2002. Human 3′-phosphoadenosine 5′-phosphosulfate synthetase 2 (PAPSS2) pharmacogenetics: gene resequencing, genetic polymorphisms and functional characterization of variant allozymes. Pharmacogenetics 12:11-21.
66. You MJ, Castrillon DH, Bastian BC, O'Hagan RC, Bosenberg MW, Parsons R, Chin L, DePinho RA. 2002. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. Proc Natl Acad Sci USA 99:1455-1460.